PTX 0.00% 4.3¢ prescient therapeutics limited

Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL, page-24

  1. 4,336 Posts.
    lightbulb Created with Sketch. 2023
    Pretty much the results published today would have been enough for an accelerated approval from a phase 2a trial.

    So they just have to keep replicating these results.

    Hopefully the next trial will see Ptx100 used as a second line of treatment drug,so results may even be better.

    Lots of de risking for the announcement today.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.